← Back to Search

Procedure

Robotic Lobectomy for Lung Cancer (OTC-RATS Trial)

N/A
Waitlist Available
Led By Moishe Liberman, MD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

OTC-RATS Trial Summary

This trial looks at performing lung cancer surgeries safely and effectively with minimally invasive techniques like VATS & RATS. It aims to recruit 20 patients with clinical stage I tumors.

Who is the study for?
This trial is for adults with early-stage lung cancer (stage I) who are already scheduled to have a lobectomy, which is surgery to remove a part of the lung, using minimally invasive techniques at CHUM. Pregnant individuals or those unable to consent are not eligible.Check my eligibility
What is being tested?
The study is testing the feasibility and safety of performing robotic-assisted thoracic surgery (RATS) lobectomies outside the traditional setting ('Outside the Cage') in patients with stage I lung cancer.See study design
What are the potential side effects?
While specific side effects aren't listed, typical risks may include complications from surgery such as pain, infection, bleeding, and issues related to anesthesia.

OTC-RATS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
30-day mortality
Conversion rate
Secondary outcome measures
Analgesic complementation requirement
Estimated blood loss
Evaluate Chronic Pain
+6 more

OTC-RATS Trial Design

1Treatment groups
Experimental Treatment
Group I: Out of the Cage Robotic LobectomyExperimental Treatment1 Intervention
Consented patients will undergo lobectomy by OTC RATS following the exact standard steps usually done by VATS/RATS, except for the incisions, that will consist in 1 to 4 subcostal ports, based on the patient and case characteristics.

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
366 Previous Clinical Trials
129,537 Total Patients Enrolled
Moishe Liberman, MDPrincipal InvestigatorCentre hospitalier de l'Université de Montréal (CHUM)
3 Previous Clinical Trials
465 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research study currently open for enrollment?

"Affirmative. Data on clinicaltrials.gov indicates that this trial, which was initially published on February 22nd 2023, is actively looking for patients to participate in it. The study aims to recruit a total of 20 individuals from 1 center."

Answered by AI

What objectives are scientists hoping to accomplish through this research endeavor?

"The primary outcome this trial will assess over a period of about 12 months is 30-day mortality. Secondary objectives include monitoring operative time, estimated blood loss, and postoperative pain using visual analog scales."

Answered by AI

What is the scope of individuals being investigated in this clinical experiment?

"Yes, it is true that this clinical trial is still seeking participants. According to the information on clinicaltrials.gov, which was last updated on April 14th 2023, the study initiated recruitment on February 22nd and aims to acquire data from 20 patients across 1 medical centre."

Answered by AI
~7 spots leftby Jun 2024